SCM
BLUE

Sigma Capital Management’s bluebird bio BLUE Stock Holding History

Sigma Capital Management’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-3,860
Closed -$1.14M – 18
2014
Q1 		$1.14M Sell
3,860
-3,739
-49% -$1.13M 0.06% 147
2013
Q4 		$2.06M Buy
+7,599
New +$2.12M 0.12% 131

Other funds holding BLUE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sigma Capital Management's BLUE Position: Q2 2014 in Review

Sigma Capital Management sold out of bluebird bio (BLUE) in Q2 2014, closing a stake of 3,860 shares — an estimated $1.14M sold.

Sigma Capital Management first reported a position in BLUE in Q4 2013 and held it in 2 quarters. The position peaked at $2.06M in Q4 2013. 104 funds tracked by Wall St. Rank hold BLUE as of Q2 2014.

  • Sigma Capital Management reported no remaining bluebird bio position as of Q2 2014 after selling out during the quarter.
  • Sigma Capital Management sold 3,860 bluebird bio shares in Q2 2014, an estimated $1.14M.
  • Sigma Capital Management first reported a position in bluebird bio in Q4 2013 and held it in 2 quarters.
  • Sigma Capital Management's bluebird bio position peaked at $2.06M in Q4 2013.
  • 104 funds tracked by Wall St. Rank held bluebird bio as of Q2 2014.

Based on Sigma Capital Management's 13F filing for Q2 2014.